AWARD OUTCOME
What happened
Gloucestershire Hospitals NHS Foundation Trust published an award-and-contract notice for Oncotype DX Breast Recurrence Score testing. The notice records a £229,500 contract with EXACT SCIENCES UK, LTD., signed on 7 October 2026, but the sole related lot is marked cancelled.
Published outcomeOne active award and one active contract record are linked to EXACT SCIENCES UK, LTD. The source states the selection used Provider Selection Regime Direct Award A because Exact Science was described as the only provider of this test type.
Market significanceThis is a specialised pathology/genomic-testing requirement procured without a prior call for competition. The stated sole-provider rationale indicates a highly concentrated supply position for the specified test.
AWARDED SUPPLIERS AND LOTS
1 supplier record analysed
EXACT SCIENCES UK, LTD.
98% confidenceAward 095328-2026-1 · Lots 1 · £229,500 GBP · Verified supplier linked to an active award and active contract record
View supporting evidence
The award names Exact Sciences UK, Ltd.; supplier verification identifies the legal company name as EXACT SCIENCES UK, LTD. (company number 07484560). The linked contract value is £229,500.
LIFECYCLE
Award or contract stage
Notice publication
99% confidence8 October 2026
View supporting evidence
The release history records an award, contract notice published at 2026-10-08T15:29:02+01:00.
Award record status
98% confidenceActive
View supporting evidence
Award 095328-2026-1 is marked active.
Contract record status
98% confidenceActive
View supporting evidence
Contract 095328-2026-1 is marked active.
Related lot status
99% confidenceCancelled
View supporting evidence
Lot 1, the only lot linked to the award, is marked cancelled.
Contract signature
99% confidence7 October 2026
View supporting evidence
Contract 095328-2026-1 gives dateSigned as 2026-10-07.
VALUES
Published values explained
Contract value
99% confidence£229,500
View supporting evidence
Contract 095328-2026-1 records a value of 229500 GBP.
Value attribution
93% confidenceSingle contract-level value linked to the sole listed award
View supporting evidence
One contract is linked to award 095328-2026-1, which names one supplier. The lot narrative also states a lifetime value of £229,500.
TIMELINE
Procurement timeline
Contract signed
99% confidence7 October 2026
View supporting evidence
The contract dateSigned field is 2026-10-07.
Notice published
99% confidence8 October 2026
View supporting evidence
The notice publication timestamp is 2026-10-08T15:29:02+01:00.
Stated service period
88% confidence1 July 2027 to 30 June 2028
View supporting evidence
The lot description states that the contract lifetime is £229,500 from 1 July 2027 until 30 June 2028.
SCOPE
What was awarded
Requirement
99% confidenceSend-away Oncotype DX Breast Recurrence Score genomic assay testing
View supporting evidence
The title and description state that the requirement is provision of the Oncotype DX Breast Recurrence Score via a genomic assay.
Service classification
99% confidencePathology services (CPV 85111800)
View supporting evidence
The procurement classification is CPV 85111800, Pathology services.
Delivery area
94% confidenceUKK13
View supporting evidence
The item delivery address specifies region UKK13.
Clinical context stated in notice
94% confidenceBreast cancer biology assessment, including supporting decisions intended to avoid unnecessary chemotherapy
View supporting evidence
The lot narrative says the test provides personalised insight into breast cancer biology and addresses chemotherapy overtreatment, particularly for patients with lymph node-positive breast cancer.
PROCEDURE
Procedure and competition
Procurement method
99% confidenceLimited procedure / award without prior publication of a call for competition
View supporting evidence
The process records procurement method 'limited' and method details 'Award procedure without prior publication of a call for competition'.
Award route stated
98% confidenceProvider Selection Regime Regulations 2023, Direct Award A
View supporting evidence
The lot description and procurement rationale state that the contract was awarded under the Health Care Services (Provider Selection Regime) Regulations 2023 Direct Award A.
Stated rationale
96% confidenceExact Science was described as the only provider of this type of test
View supporting evidence
The procurement rationale says the award route was used because Exact Science was the only provider of this type of test.
Competition information
99% confidenceNo competition or bid-count information supplied
View supporting evidence
The published fields provide a direct-award rationale but no bidder count, tender submissions, evaluation scores or comparative assessment.
Award criterion
91% confidencePrice
View supporting evidence
Lot 1 award criteria lists price.
CONTRACT TERMS
Published contract terms
Contract record
99% confidenceActive contract record, signed 7 October 2026
View supporting evidence
The contract is marked active and contains a dateSigned of 2026-10-07.
Stated duration
88% confidence12 months: 1 July 2027 to 30 June 2028
View supporting evidence
The lot narrative gives these start and end dates.
Options
97% confidenceNo options stated
View supporting evidence
Lot 1 hasOptions is false.
Extensions or renewals
99% confidenceNot supplied
View supporting evidence
No extension or renewal terms are included in the published fields.
COMMERCIAL VIEW
Commercial observations
Market structure signal
96% confidenceThe buyer’s stated rationale presents the specified test as sole-provider supply.
View supporting evidence
The procurement rationale says Exact Science was the only provider of this type of test.
Route-to-market signal
99% confidenceThe requirement was sourced through a direct award rather than a prior competitive call.
View supporting evidence
The notice identifies a limited procedure without prior publication and PSR Direct Award A.
Commercial comparability
99% confidenceNo published unit pricing, volumes, pricing schedule, bid comparison or evaluation scoring.
View supporting evidence
These details are absent from the supplied notice fields.
DATA QUALITY
Gaps and source limitations
Material status inconsistency
99% confidenceThe active award and active signed-contract records are linked only to Lot 1, which is marked cancelled.
View supporting evidence
Award 095328-2026-1 and contract 095328-2026-1 are active; the award’s relatedLots field is ["1"]; Lot 1 status is cancelled.
Term dates location
98% confidenceProcess-level contract start and end fields are blank; dates appear only in the cancelled lot narrative.
View supporting evidence
contract_start_at and contract_end_at are null, while the lot description states 1 July 2027 to 30 June 2028.
Information not supplied in the published notice
99% confidenceNo bid count, evaluation scores, award date, pricing breakdown, volumes, extension terms or lot-level value are supplied.
View supporting evidence
The relevant supplied fields are null or absent.
Supplier identity quality
99% confidenceSupplier identity is verified through an exact-name company match.
View supporting evidence
Supplier verification status is verified, with match method exact_name and verified company number 07484560.
SOURCE DATA LIMITATIONS
Information not supplied in the published notice
- The sole linked lot is marked cancelled while the related award and contract are active; the supplied data does not resolve this conflict.
- Process-level contract start and end dates are not populated. The stated 1 July 2027 to 30 June 2028 period appears only in the cancelled lot description.
- Information not supplied in the published notice: award date, bid count, evaluation detail, scores, volumes, unit prices, pricing breakdown, lot-level value, and renewal or extension terms.
MARKET THEMES
Relevant award themes
EXACT SCIENCES UK, LTD.Gloucestershire Hospitals NHS Foundation TrustOncotype DX Breast Recurrence Scoregenomic assaypathology servicesProvider Selection RegimeDirect Award A
COMMON QUESTIONS
About this award
Who was named as supplier for the Oncotype DX testing requirement?
The award names Exact Sciences UK, Ltd. Supplier verification identifies the legal company name as EXACT SCIENCES UK, LTD. (company number 07484560).
What is the recorded contract value?
The linked contract record states £229,500 GBP.
Was the contract signed?
Yes. The contract record explicitly gives a signature date of 7 October 2026.
What procurement route was stated?
The notice states Provider Selection Regime Direct Award A, without prior publication of a call for competition.
Is there a data issue in the notice?
Yes. The award and contract records are active, but their only linked lot is marked cancelled.
ProcuraAxis award analysis supplements, but does not replace, the official award notice, contract data or procurement documents. “Awarded” does not by itself prove that a contract has been signed.